An overview of lipid abnormalities in patients with inflammatory bowel disease
about
Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implicationsSpeckle Tracking Stress Echocardiography Uncovers Early Subclinical Cardiac Involvement in Pediatric Patients with Inflammatory Bowel Diseases.Microbiota regulate intestinal epithelial gene expression by suppressing the transcription factor Hepatocyte nuclear factor 4 alphaGenetic association of apolipoprotein E polymorphisms with inflammatory bowel diseaseInsights into the Role of Erysipelotrichaceae in the Human Host.Inflammatory and Lipid-Associated Markers of Cardiovascular Diseases in Children with First Exacerbation of Inflammatory Bowel Disease.Association of tumor necrosis factor-α and -β gene polymorphisms in inflammatory bowel disease.Associations of Bowel Movement Frequency with Risk of Cardiovascular Disease and Mortality among US Women.Epithelial Cholesterol Deficiency Attenuates Human Antigen R-linked Pro-inflammatory Stimulation via an SREBP2-linked Circuit.Molecular classification of Crohn's disease reveals two clinically relevant subtypes.Trios-promising in silico biomarkers for differentiating the effect of disease on the human microbiome network.Endocrine and metabolic manifestations in inflammatory bowel diseaseTranscription factor TFEB cell-autonomously modulates susceptibility to intestinal epithelial cell injury in vivo.Sharing of Genes and Pathways Across Complex Phenotypes: A Multilevel Genome-Wide Analysis.Favorable Effect of Anti-TNF Therapy on Insulin Sensitivity in Nonobese, Nondiabetic Patients with Inflammatory Bowel Disease.
P2860
Q26774558-0B21E93C-F3A8-4599-B492-E50567517FA5Q33774260-739A4674-9FD2-469B-A337-7F6DE2E38A3FQ33865173-1F15326C-AEB1-4DB6-9255-822B90AEFFF0Q34986020-8FC4520E-9236-4F41-9F6E-67082FFCB6E1Q35860778-558DBFD4-7BD5-42D5-876D-A52C01626179Q37029473-F06BD37D-F57E-4AC7-89A3-948D2BB2F8F3Q37033219-78F81D8D-082B-43B7-8AD6-B15BD13F7FB5Q37232667-FA38A5A7-28EA-47B8-91BC-FB47282DE316Q38409702-D1555C95-6298-44A7-B2D2-C8E81D19F488Q39289701-86AD57F5-E7CF-44E2-8918-F30C8797D030Q42379025-B34D9C13-F29D-42F5-A796-51F6F08F73A0Q42406756-BEC3C386-8285-4EF6-9546-9303B1D7F589Q42636973-B1604FE6-7A5D-4607-83C9-ABE056BC0E42Q48155517-D2F9C667-D48A-461C-952E-ED80DB8F7BD8Q51244473-1A5F9AA7-0CD9-40D9-BF71-18281A842787
P2860
An overview of lipid abnormalities in patients with inflammatory bowel disease
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
An overview of lipid abnormalities in patients with inflammatory bowel disease
@en
An overview of lipid abnormalities in patients with inflammatory bowel disease
@nl
type
label
An overview of lipid abnormalities in patients with inflammatory bowel disease
@en
An overview of lipid abnormalities in patients with inflammatory bowel disease
@nl
prefLabel
An overview of lipid abnormalities in patients with inflammatory bowel disease
@en
An overview of lipid abnormalities in patients with inflammatory bowel disease
@nl
P2860
P1476
An overview of lipid abnormalities in patients with inflammatory bowel disease
@en
P2093
Aris P Agouridis
Haralampos J Milionis
P2860
P304
P50
P577
2011-01-01T00:00:00Z